Metabolic, mental health, behavioural and socioeconomic characteristics of migrants with Chagas disease in a non-endemic country

Tropical Medicine and International Health

Volumn 17, Issue 5, 2012, Pages 595-603

  Jackson, Yves ^a   Castillo, Sara ^b   Hammond, Perle ^b   Besson, Marius ^a   Brawand Bron, Anne ^a   Urzola, Diana ^a   Gaspoz, Jean Michel ^a   Chappuis, François ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Cardiovascular disease; Chagas disease; Europe; Migrants; Prevention; Risk factors

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHAGAS DISEASE; DIABETES; DISEASE PREVALENCE; HEALTH IMPACT; LIFESTYLE; MENTAL HEALTH; METABOLISM; MIGRATORY POPULATION; PATHOGEN; POVERTY; QUESTIONNAIRE SURVEY; RISK FACTOR; SOCIOECONOMIC CONDITIONS;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; BEHAVIOR; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CHAGAS DISEASE; DEPRESSION; FEMALE; HISPANIC; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; METABOLIC SYNDROME X; METABOLISM; MIGRATION; OBESITY; PATIENT ASSESSMENT; PREVALENCE; SEDENTARY LIFESTYLE; SMOKING; SOCIOECONOMICS;

ADOLESCENT; ADULT; BOLIVIA; CARDIOVASCULAR DISEASES; CHAGAS DISEASE; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; EMIGRANTS AND IMMIGRANTS; EUROPE; FEMALE; HEALTH BEHAVIOR; HUMANS; LATIN AMERICA; MALE; MENTAL DISORDERS; METABOLIC DISEASES; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEDENTARY LIFESTYLE; SMOKING; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EUROPE; LATIN AMERICA;

EID: 84859954465     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2012.02965.x     Document Type: Article

References (36)

1. Andrade F (2009) Estimating diabetes and diabetes-free life expectancy in Mexico and seven major cities in Latin America and the Caribbean. Revista Panamericana de Salud Pública 26(1), 9-16.
2. Angheben A, Anselmi M, Andreoni F, et al. (2011) Stronglyoidiasis and Chagas disease sero-prevalence in a Bolivian community, Italy. Tropical Medicine & International Health 16(S1), 94.
3. Briceno-Leon R & Mendez Galvan J (2007) The social determinants of Chagas disease and the transformations of Latin America. Memórias do Instituto Oswaldo Cruz 102(Suppl 1), 109-112.
4. Cappuccio FP, D'Elia L, Strazzullo P & Miller MA (2010) Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 33(5), 585-592.
5. Coura JR & Vinas PA (2010) Chagas disease: a new worldwide challenge. Nature 465(n7301_supp), S6-S7.
6. D'Agostino RB, Vasan RS, Pencina MJ, et al. (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117(6), 743-753.
7. Danaei G, Finucane MM, Lin JK, et al. (2011a) National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 377(9765), 568-577.
8. Danaei G, Finucane MM, Lu Y, et al. (2011b) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 377(9765), 31-40.
9. De Angelis Alves R, De Almeida E, Da Silva Wanderley J & Guariento M (2009) Chagas' disease and ageing: the coexistence of other chronic diseases with Chagas' disease. The Revista da Sociedade Brasileira de Medicina Tropica 42(6), 622-628.
10. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI & Moller HJ (2009) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry 24(6), 412-424.
11. Farzadfar F, Finucane MM, Danaei G, et al. (2011) National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 377(9765), 578-586.
12. Ferrie JE, Shipley MJ, Stansfeld SA & Marmot MG (2002) Effects of chronic job insecurity and change in job security on self reported health, minor psychiatric morbidity, physiological measures, and health related behaviours in British civil servants: the Whitehall II study. Journal of Epidemiology & Community Health 56(6), 450-454.
13. Finucane MM, Stevens GA, Cowan MJ, et al. (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377(9765), 557-567.
14. Ford ES (2005) Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28(7), 1769-1778.
15. Ford ES, Li C & Sattar N (2008) Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 31(9), 1898-1904.
16. Gascon J, Bern C & Pinazo MJ (2009) Chagas disease in Spain, the United States and other non-endemic countries. Acta Tropica 115(1-2), 22-27.
17. Hermann C (1997) International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. Journal of Psychosomatic Research 42(1), 17-41.
18. Jackson Y, Angheben A, Carrilero Fernandez B, et al. (2009a) Management of Chagas disease in Europe. Experiences and challenges in Spain, Switzerland and Italy. Bulletin de la Société de Pathologie Exotique 102(5), 326-329.
19. Jackson Y, Myers C, Diana A, et al. (2009b) Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerging Infectious Diseases 15(4), 601-603.
20. Jackson Y, Alirol E, Getaz L, et al. (2010a) Tolerance and safety of nifurtimox in patients with chronic chagas disease. Clinical Infectious Diseases 51(10), e69-e75. Available: Accessed 2011 July 15
21. Jackson Y, Getaz L, Wolff H, et al. (2010b) Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Neglected Tropical Diseases 4(2), e592. Accessed 14/7/2011.
22. Marmot M (2009) Closing the health gap in a generation: the work of the Commission on Social Determinants of Health and its recommendations. Global Health Promotion (Suppl 1, 23-27.
23. Munoz J, Gomez i Prat J, Gallego M, et al. (2009) Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Tropica 111(1), 51-55.
24. PAHO (Organizacion Panamericana de la Salud) (2006). Estimacion cuantitativa de la enfermedad de Chagas en las Americas. PAHO, Montevideo, Uruguay.
25. Posada E, Pell C, Angulo M, et al. (2011) Bolivian migrants with Chagas disease in Barcelona, Spain: a qualitative study of dietary changes and digestive problems. International Health 3, 289-294.
26. Ozaki Y, Guariento ME & de Almeida EA (2010) Quality of life and depressive symptoms in Chagas disease patients. Quality of Life Research 20(1), 133-138.
27. Perez-Ayala A, Perez-Molina JA, Norman F, et al. (2011) Chagas disease in Latin American migrants: a Spanish challenge. Clinical Microbiology 17(7), 1108-1113.
28. Quintana JM, Padierna A, Esteban C, et al. (2003) Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica 107(3), 216-221.
29. Rassi A Jr, Rassi A & Marin-Neto JA (2010) Chagas disease. Lancet 375(9723), 1388-1402.
30. Schargrodsky H, Hernandez-Hernandez R, Champagne BM, et al. (2008) CARMELA: assessment of cardiovascular risk in seven Latin American cities. American Journal of Medicine 121(1), 58-65.
31. The Institute of Medicine (2002) Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care: Institute of Medicine. National Academy of Science, Washington DC, 764 pp.
32. Viotti R, Vigliano CA, Alvarez MG, et al. (2009) The impact of socioeconomic conditions on chronic Chagas disease progression. Revista Española de Cardiología 62(11), 1224-1232.
33. Wilkinson R & Marmot M (2003) Social Determinants of Health: The Solid Facts. World Health Organization, Geneva.
34. World Health Organization (WHO) (2002) Control of Chagas Disease. Second report of the WHO experts committee. Technical report series no 995. World Health Organization, Geneva.
35. World Health Organization (WHO) (2009) Control and Prevention of Chagas Disease in Europe. Report of a WHO informal consultation (jointly organized by WHO headquarters and the WHO regional office for Europe). World Health Organization, Geneva. Accessed 14/7/2011.
36. World Health Organization (WHO) (2011) World Health Statistics 2011. WHO, Geneva; Accessed 15/7/2011.